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Summary
The cellular changes during ageing are incompletely understood yet immune
system dysfunction is implicated in the age-related decline in health. The
acquired immune system shows a functional decline in ability to respond to
new pathogens whereas serum levels of cytokines are elevated with age.
Despite these age-associated increases in circulating cytokines, the function of
agedmacrophages is decreased. Pathogen-associatedmolecular pattern recep-
tors such as Toll-like receptors (TLRs) are vital in the response of macroph-
ages to pathological stimuli. Here we review the evidence for defective TLR
signalling in normal ageing. Gene transcription, protein expression and cell
surface expression of members of the TLR family of receptors and co-effector
molecules do not show a consistent age-dependent change across model
systems. However, there is evidence for impaired downstream signalling
events, including inhibition of positive and activation of negative modulators
of TLR induced signalling events. In this paper we hypothesize that despite a
poor inflammatory response via TLR activation, the ineffective clearance of
pathogens by macrophages increases the duration of their activation and
contributes to perpetuation of inflammatory responses and ageing.
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Introduction
Ageing is a biological phenomenon which occurs in all
organisms. That dysfunction of the immune system occurs
has been well described [1]; a decline in the normal func-
tioning of the acquired (or adaptive) immune system [2]
with a shift in the T cell population from naive T cells to
memory T cells [3] leads to reduced immunization efficacy
and poor acquired immune response to new pathogens. The
ageing innate immune response is more complex, with
increased neutrophil recruitment but decreased specific
activity [1]. Similarly, a poor acute phase protein response
has been described in ageing mice in response to inflamma-
tory challenge and is associated with significant tissue
damage [4,5]. Paradoxically, circulating levels of the inflam-
matory cytokines, particularly of the acute phase protein
inducer interleukin (IL)-6, are enhanced, although it is
unclear whether downstream signalling following ligand–
receptor interaction maintains its efficiency with ageing
[4,5]. Cross-talk exists between the innate immune system
and the acquired immune system through shared receptors;
Toll-like receptor (TLR)-mediated priming of T cell and B
cell responses enhances development [6–8] of the acquired
immune response, therefore age-related dysfunction of TLR
function could potentially impact upon the effectiveness of
both the innate and acquired immune systems. Collectively,
the ageing immune system results in increased risk of infec-
tion and reduces ability to remove infectious pathogens,
resulting in an increased risk of infection-dependent mor-
bidity and mortality [9]. Age-associated defects in the
acquired immune system and the inability to eliminate
foreign pathogens or cancerous cells leads to a proinflamma-
tory environment with elevated circulating cytokine levels
[10,11]; this associates with an increased risk of a diverse
range of disease such as rheumatoid arthritis, cardiovascular
disease and cancers, arising in part from a failure to resolve
acute inflammatory events [12]. The purpose of this review
is to focus upon human ageing in the absence of disease or
chronic pathophysiology.
Free radicals and ageing
According to the free radical theory of ageing [13], reactive
oxygen species (ROS) are responsible for sustained damage
to DNA, proteins and lipids; and the accumulation of
damaged biological macromolecules is responsible for
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biological ageing and age-associated pathologies. ROS are
produced as normal by-products of molecular respiration
from the electron transport chain [14] and their production
by the phagocytic nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase constitutes a critical part of the first
line of defence against pathogens. Chronic granulomatous
disease patients who lack specific components of NADPH
oxidase and fail to produce significant ROS during the res-
piratory burst suffer persistent bacterial infection, demon-
strating the importance of the respiratory burst for pathogen
removal.
The phagocytic respiratory burst in isolated neutrophils
from older adults is reported variably as increased and
decreased [1]; the discrepancy here may relate to ligand dif-
ferences between studies, e.g. CD14- versus CD16-mediated
activation, and raises the intriguing possibility that intracel-
lular signalling pathways may be affected differentially by
age. Moreover, mitochondrial respiratory chain integrity is
diminished and ROS leakage increased during ageing, due
principally to cytochrome oxidase dysfunction [15].
Both the mitochondrion and NADPH oxidase isoforms
are potential sources of ageing-related excessive ROS pro-
duction [16,17]. The reduction or abrogation of age-
associated pathologies via anti-oxidant supplementation
[18] or by overexpression of cellular anti-oxidant defence
enzymes in mitochondria [19,20] supports this concept,
although this wisdom has been challenged recently in mice
[4]; the overexpression of major anti-oxidant enzymes was
shown to be insufficient to extend their lifespan. A number
of species-specific differences in the innate immunity and
macrophage biology have been documented that are relevant
to ageing and warrant caution in the extrapolation of obser-
vations between species (reviewed previously [21,22]).
TLRs and ligand speciﬁcity
First described in 1997 [23], TLRs are a recently discovered
family in the transduction of an inflammatory stimulus and
mediate many aspects of the immune response, including
major histocompatibility complex (MHC) expression, anti-
body production and the expression of cytokines, chemok-
ines and adhesion molecules (reviewed in [24]). Currently,
13 TLRs (10 human), activating a signalling cascade in
response to structurally distinct stimuli, have been
described: bacterial lipoproteins are recognized by either
TLR-1/2 or TLR-2/6 heterodimer complexes, viral double-
stranded RNA is recognized by TLR-3, the endotoxin
lipopolysaccharide (LPS) from Gram-negative bacteria is
recognized by TLR-4, TLR-5 recognizes bacterial flagella
proteins, whereas TLRs 7–9 detect pathogenic nucleic acids
summarized in Table 1 (adapted from [24]).
TLRs are found on cells of the innate immune system
including monocytes, macrophages, dendritic cells, epithe-
lial and endothelial cells. TLRs are related closely to the IL-1
receptor, both of which contain cytoplasmic Toll/IL-1 recep-
tor (TIR) domains. Although TLRs show a high level of
intracellular structural similarity to the IL-1 receptor, the
extracellular domains are distinctly different [25], with TLRs
having a number of leucine-rich repeats in the place of the
immunoglobulin (Ig)G-like domains found on the extracel-
lular portion of the IL-1 receptor.
TLR activation requires the recruitment of a number of
adaptor molecules. All TLRs, with the exception of TLR-3,
require myeloid differentiation primary response gene 88
(MyD88) to function [24]. MyD88 is important in the
expression of LPS-induced IL-1 and is also recruited by the
IL-1 receptor via a TIR domain, where MyD88-deficient
mice are resistant to LPS-induced endotoxaemia [24]. In
addition, MyD88-/- mice are protected from LPS-induced
sepsis due to the inability to produce cytokines and proin-
flammatory proteins in the presence of slow-activated
nuclear factor kB (NF-kB) [24]. The slow and fast pathways
are considered distinct from one another, even though some
downstream elements are common to both pathways, and
are termed the MyD88-dependent pathway (fast: MyD88
and Mal) [26], and the MyD88-independent pathway (slow:
TRAM and TRIF) [26,27]. The MyD88-dependent pathway
is involved in the immediate responses to a bacterial infec-
tion and stimulates bactericidal compound production such
as reactive nitrogen species (RNS), nitric oxide (NO), via
inducible nitric oxide synthase (iNOS) activation, and proin-
flammatory cytokines such as tumour necrosis factor
(TNF)-a. In contrast, the MyD88-independent pathway
activates after approximately 30 min from the original LPS
stimulation due to TRAM/TRIF signalling from endosomes
following receptor internalization (Fig. 1).
Macrophage TLR function in ageing
Age-associated defects in the acquired immune system asso-
ciate with increased recruitment of phagocytic cells [1].
Macrophages are vital in the immune response and are the
major producers of RNS and cytokines in response to micro-
bial infectious stimuli such as LPS, lipoteichoic acid (LTA)
and pathogenic nucleic acids, and endogenous danger
signals such as oxidized proteins and lipids, TNF-a and heat
shock proteins (HSPs) [28]. However, ageing in mice is asso-
ciated with an increase in the number of bone marrow mac-
rophages that have an impaired ability to generate or release
cytokines. The increase in macrophage numbers may reflect
a compensation for their reduced function [29]. Studies in
mice show that circulating IL-6 is increased significantly
with age upon stimulation with LPS, although its down-
stream signalling capacity appears limited [19,30].
Stimulation of macrophages explanted from ageing mice
with LPS increases the anti-inflammatory cytokine IL-10
and reduces endotoxin-induced production of the proin-
flammatory cytokines TNF-a, IL-1b, IL-6 and IL-12
[31–34], nitric oxide and expression of inducible nitric oxide
synthase [34]. Reduced TLR-mediated function in alveolar
C. R. Dunston and H. R. Griffiths
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macrophages from the ageing rat in response to the TLR-4
ligand LPS [35] is shown by significant decreases in ROS and
RNS production.
A similar pattern is observed in humans; in vivo, cytokine
production is increased with age [36–38]; however, produc-
tion of IL-6 and TNF-a was decreased with the TLR-1/2
heterodimer ligand N-palmitoyl-S-[2,3-bis(palmitolyoxy)-
(2R,S)-propyl]-Cys-[S]-Ser-[S]-Lys(4)trihydrochloride
(Pam3CSK4) in macrophages from aged [74·6 (65–89)
years] compared to young [25·7 (22–30) years] individuals
[39]. This apparent paradox of low cellular production and
high plasma cytokine levels may be resolved by considering
that with age, macrophages remain activated for longer and
by multiple stimuli; have an increased lifespan; or if proin-
flammatory cytokine production switches from the mac-
rophage to another cell type during the ageing process; cells
that are not typically involved in the innate immune
response such as T cells, B cells and epithelial cells are able to
produce cytokines in response to TLR ligands.
There are a number of TLR modulators that are elevated
during ageing and include circulating hormones, free fatty
acids and immunoglobulins [27]. These play important
regulatory roles in switching off signalling responses to
pathogenic stimuli, for example by an increase in prostag-
landin E2 (PGE2) production that in turn triggers intracellu-
lar cyclic AMP-dependent protein kinase A (PKA) activation
and reduces the expression of TLR-4 [27]. Moreover, a
number of endogenous TLR ligands that have been identi-
fied and are known to increase during ageing include oxi-
dized proteins and lipids, advanced glycation end-products
(AGEs) [40] and HSPs [28], may modify the macrophage
response to exogenous TLR ligands.
TLR expression in ageing
The molecular mechanisms for the reduction in TLR func-
tion may be explained by decreased functional protein
expression. Laing et al. [41] investigated the expression of
TLRs 1, 2, 4, 5 and 6 in peritoneal macrophages from young
(8–10 weeks) and old (>18 months) BALB/cByJL mice. Basal
level of TLR-5 transcription alone was altered in the aged
group, showing a relative expression of 0·06 of mRNA tran-
Fig. 1. Toll-like receptor (TLR)-mediated
signalling pathways and adaptor proteins.
Ligation of TLR results in receptor dimerization
and subsequent recruitment of Mal and
myeloid differentiation factor 88 (MyD88),
interleukin 1 receptor associated kinase (IRAK)
and tumour necrosis factor receptor associated
factor (TRAF)-6 molecules lead to activation of
nuclear factor (NF)-kB and mitogen-activated
protein kinase (MAPK) pathways. This
results in transcriptional activation of
proinflammatory genes including cytokines.
A delayed response is also activated by TLR
dimerization, probably activated after
endosomal internalization of the TLR-4
homodimer. This involves recruitment of
TRAM and TRIF resulting in a delayed NF-kB
activation and transcription via interferon
regulatory factor (IRF)3 activation of late genes
such as interferon.
C. R. Dunston and H. R. Griffiths
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script compared to the young group. Only TLR-5 transcrip-
tion was altered when macrophages were activated with
the Gram-negative bacterium Porphyromonas gingivalis.
However, although TLR-5 transcription was reduced in mac-
rophages from the aged group, this was not reflected in
reduced receptor expression at the cell surface (Liang et al.
[41]). In contrast, the level of TLR-2 surface expression was
reduced by a significant, amount, although no changes in
mRNA levels of TLR-2 were observed, highlighting the
importance of studying functional receptor levels and not
just the transcript.
mRNA levels of TLRs 1–9 are reduced in unstimulated
splenic macrophages and also in peritoneal macrophages
from old (18–24 months) compared to young (2–3 months)
C57BL/6 mice [33]. In contrast, Renshaw et al. [33] demon-
strated an associated decrease in cell surface expression of
TLR-4 which correlated with a functional reduction in TLR
activity as reduced IL-6 and TNF-a production in response
to LPS, Poly (I:C), zymosan A, Staphylococcus aureus, flagel-
lin, and oligodeoxynucleotide cytosine guanine (ODN
CpG). Renshaw et al. [33] showed that after TLR-9 (which
was not analysed by Liang et al.), TLR-5 showed the largest
alteration in transcript level, suggesting that assay sensitivity
could explain the discordant mRNA data.
Another study [31] in mouse models has shown that
although LPS-induced TNF-a production is reduced with
age, the levels of TLR-4 cell surface expression are not
altered; these authors suggest that the mitogen-activated
protein kinase (MAPK) signalling pathways downstream of
TLR activation are affected by age (discussed below), but that
the reduction in TLR functionality is not due to defects at the
TLR level.
Cell surface expression of TLR1 is reduced by 36%, but the
cell surface expression of TLR-2 is not altered significantly
with age [39]. This TLR defect appeared to be isolated to
TLR-1, as TLR-2 ligands elicited no age-dependent alteration
in function. Further investigation showed no significant
change in whole cell expression levels of TLR-1 protein. The
reduced cell surface TLR-1 expression coupled with the lack
of change to total protein levels of TLR-1 suggests that some
process which is essential for cell membrane targeting may
be subject to age-mediated dysfunction.
Trafficking is affected by the degree of post-translational
modification (PTM). All TLRs undergo N-glycosylation
[42,43] and defects of N-glycoslyation activity have been
implicated in ageing [44], but as yet are not associated with
TLR dysfunction in ageing. Other essential PTMs required
for TLR-1 function are the formation of a number of disul-
phide bridges [43,45,46]. Formation of disulphide bridges is
controlled within the endoplasmic reticulum (ER) by the
action of protein disulphide isomerase (PDI), and recent
reports suggest that enhanced ROS and RNS associated with
ageing may induce a nitrosyl post-translational modification
to PDI impairing its function; an effect that has been linked
to the misfolding of the NMDA receptor [47]. It is clear that
an age-related decline and activity of key molecular chaper-
ones and folding enzymes in the ER compromises proper
protein folding. These changes, together with an impaired
adaptive unfolded protein response, have been implicated in
receptor dysfunction in the nervous system and implications
for TLRs have not yet been explored [48].
The importance of TLR expression in age-related TLR
dysfunction remains unclear. More extensive human studies
should be conducted with conformation-sensitive antibod-
ies in order to establish the importance of TLR surface
expression in aged individuals. Also the role of PTMs on
TLRs, and their contribution to functional activity and
expression, should be investigated in the context of ageing.
TLR adaptor molecules and age
TLR-induced macrophage activation requires recruitment of
a number of adaptor molecules. In the case of TLR-4, extra-
cellular co-stimulatory molecules include soluble (s)CD14
and membrane-bound (m)CD14, MD-2 and LPS binding
protein (LBP). Serum levels of LBP are unaltered in aged
mice or humans. However, expression of CD14 onmacroph-
ages is reduced in mice, as are mRNA levels of MD-2, a key
regulator for LPS-induced TLR-4 activation.
A number of intracellular molecules have been identified
as essential for TLR-mediated signalling, including MyD88,
which is essential in the signal transduction from all TLRs
with the exception of the endosomally located TLR-3
(Fig. 1). MyD88 adaptor-like protein [Mal; also called TIR
domain containing adaptor protein (TIRAP)] is also
required for MyD88-dependent TLR signalling and is used
by all TLRs except TLR-3. MyD88/Mal are associated with
IL-1 receptor-associated kinase (IRAK)-1 and -4; upon
MyD88/Mal activation IRAK-1/-4 are phosphorylated and
dissociate from the MyD88/Mal complex eliciting a cascade
of phosphorylation events. IRAK-1 and IRAK-4 themselves
have serine/threonine kinase activity and upon dissociation
from MyD88/Mal activate TNF receptor-associated factor
(TRAF)-6 by phosphorylation. TRAF6 phosphorylates
transforming growth factor (TGF)-b-activated kinase
(TAK)-1 which, in turn, activates the mitogen-activated
protein kinase (MAPK) and NF-kB pathways (discussed
below).
Ineffective signalling from TLR via adaptor molecules in
the age-associated decline in adaptive immunity presents an
attractive mechanism for failure to elicit cytokine produc-
tion in response to ligand activation in light of the conflict-
ing data regarding age-dependent changes in TLR function
but not expression. Microarray analysis of mRNA from
young (4 months) murine macrophages compared to aged
macrophages (20–22 months) demonstrated a decrease in
both basal and LPS-stimulated levels of MyD88 [34];
however, the same study showed an increase in mRNA levels
of Mal confirmed by both microarray analysis and poly-
merase chain reaction (PCR) that was not confirmed at the
Toll-like receptors, macrophages, ageing
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protein level. Levels of IRAK-1 were also up-regulated in
response to LPS stimulation but not basally in aged mice
compared to youngmice. In contrast, the level of the IRAK-1
substrate, TRAF6, was decreased significantly. Another
potential target for age-related decline in signal transduction
from the receptor involves MD-2, which has an absolute
requirement for two cysteine residues, probably to form a
disulphide bridge with TLR-4 after ligand binding [49].
Given the altered intracellular redox environment associated
with ageing that favours irreversible thiol oxidation due to
glutathione insufficiency, oxidative PTMs to MD-2 are also
probable candidates to explain an age-associated decline in
response to extracellular ligands [50].
TLR mRNA analysis suggests altered expression with age,
but protein expression and therefore the functional impact
of these alterations in transcriptional regulation of TLR
adaptor molecules has yet to be confirmed.
Although few data are available on age-related MyD88-
independent dysfunction, LPS-stimulated IFN-g production
in human monocytes is decreased with age [51,52]. Also
members of the family of IFN regulatory factors have been
shown to be increased in response to TLR-9 activation [53].
Suppressors of TLR signalling in age
Excessive activation or aberrant stimulation of TLR signal-
ling pathways can contribute to endotoxic shock and chronic
inflammatory diseases, such as periodontitis [31]. Therefore,
a number of physiological negative regulatory mechanisms
exist to ‘switch off’ TLR signals.
One of the major ways in which TLR signalling is regu-
lated is by the controlled disassembly and degradation of
adaptor molecules associated with the activated TLR
complex. One such adaptor molecule which is removed after
TLR activation is mal; mal contains a TIR domain and is
therefore recruited upon ligand-induced TLR dimerization;
mal acts as a molecular bridge to aid in the recruitment of
MyD88. Following activation of TLR and recruitment of
mal, mal undergoes Bruton’s tyrosine kinase (Btk)-induced
phosphorylation, causing it to become a substrate for
suppressor of cytokine signalling (SOCS)-1 dependent
ubiquitination. Polyubiquitinated mal is then directed for
degradation via the 26S proteasome. The contribution of the
SOCS family of proteins in age-mediated TLR dysfunction is
at present unclear, but increased levels of SOCS are reported
in rodent brain tissue [54], human muscle tissue [55] and
human neutrophils [56] supporting an age-associated accel-
erated degradation of the TLR signalling complex.
Increased levels of IRAK-M mRNA have been observed
with increased age in mice [57]. During TLR signalling,
IRAK-1 associates with TRAF6 resulting in activation via
phosphorylation. In contrast, IRAK-M, although sharing
much homology to IRAK-1, lacks catalytic kinase activity
and during TLR signalling IRAK-M inhibits the association
of IRAK-1 with TRAF6, thereby inhibiting downstream
TLR-induced MAPK and activation. IRAK-M, unlike other
members of the IRAK family, is restricted in its expression to
monocytes and macrophages, whereas other IRAKs are
expressed ubiquitously throughout the body. It remains to be
determined whether IRAK-M protein levels map the changes
reported previously at the mRNA level, i.e. are increased
during ageing, as this would probably translate into reduced
downstream signalling from the receptor.
Other mechanisms of TLR negative regulation include
modulation by the reactive intermediate 4-hydroxynonenal
(4HNE) [58]. 4HNE is a product of lipid peroxidation and is
found to be increased during ageing as well as in a number of
pathologies, including Alzheimer’s disease and cancer. LPS-
induced TNF-a, IL-6 and IL-1b responses are reduced when
monocytes are treated with 4HNE; this is accompanied by
decreased NF-kB activation and reduced phagocytic activity.
To effect this change, 4HNE forms adducts with TLR4 at
reactive cysteine residues, consequently inhibiting TLR4
dimerization and therefore subsequent signalling [58].
These examples of inhibitors of TLR activation and sig-
nalling are part of a large and diverse group of mechanisms
established to maintain balance in the immune system; dys-
function of TLR signalling could arise from either decreased
activation of components of TLR signalling or increased
activity of negative regulators of TLR function, and evidence
in favour of increased modulation of negative regulation of
TLR signalling is emerging.
TLR signalling
Subsequent to activation of the TLR and recruitment of
adaptors to the complex, TRAF6 phosphorylates TAK-1
which in turn activates the MAPK cascade, a pleiotropic
signalling pathway that is activated by many inflammatory
stimuli.
MAPK
TheMAPK family is comprised of three groups: extracellular
regulated kinase 1/2 (ERK 1/2), c-jun N-terminal kinase
(JNK) and p38 MAPK. MAPKs are activated via phospho-
rylation of a specific threonine-X-tyrosine motif of which
the amino acid separating the two phosphorylation sites
differs between the different families of MAPK and is
glutamate, proline or glycine in ERK, JNK or p38 MAPK
families, respectively. Members of the MAPK family are
phosphorylated and activated by proline-directed dual spe-
cific MAPK kinases (MAPKK, MEK), which are themselves
activated via phosphorylation reactions that are mediated by
MAPKK kinase (MAPKKK, MEKK) enzymes, TAK-1 is a
TLR-activated MEKK. In the activation of p38 MAPK,
TAK-1 activates MEK3/6 which, in turn, activates p38
MAPK. TAK-1-mediated JNK activation is mediated via
MEK7 (reviewed in [59]). Figure 1 indicates the integration
of TLR activation to the MAPK cascade.
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The role of MAPK pathways in TLR-induced cytokine
production is vital; genetic manipulation or pharmacologi-
cal inhibition of MAPK proteins decreases the LPS
response. MAPK phosphorylation is reduced during ageing
[31], and when normalized to a housekeeping gene such as
b-actin confirms that total protein levels of JNK and p38
MAPK are reduced in aged individuals compared to young
adults. The reduced MAPK function in age appears to be
twofold; first there is a reduction in phosphorylated JNK
and p38 when normalized to total protein levels of JNK
and p38, and also the total protein levels are reduced. This
has been confirmed by examining the phosphorylation of
MAPK-activated protein kinase (MAPKAPK) 2, a substrate
for p38 MAPK, which was shown to be reduced in LPS-
stimulated macrophages from young mice compared to
aged mice [31].
MAPKs are regulated negatively by dual specific phos-
phatases (DUSPs). To date, a single report has described a
decrease in DUSP-10 mRNA levels in a murine model of
ageing and if translated to protein, this would suggest an
enhanced signalling response via the MAPK cascade [60].
However, this is inconsistent with the observed reports of no
change to or a reduction in MAPK signalling with age. No
specific investigation has been conducted into the function
of negative regulators of MAPKs focusing specifically on the
macrophage, nor is it known whether the generic changes
observed at the mRNA level are translated into changes in
protein expression or function.
NF-kB
NF-kB is one of the most important transcriptional regula-
tors of the innate immune response and also has important
roles in controlling cell death (Phillips et al. [61]). It is acti-
vated by a number of different stimuli ranging from exog-
enous bacterial and viral pathogens to endogenous ligands
such as TNF-a via the TNF-a receptor and AGEs via the
receptor for AGE (RAGE).
Activation of NF-kB is initiated via the activation of
inhibitor of kB (IkB) kinase (IKK) complex. The IKK
complex is formed of a number of proteins: IKKa, IKKb and
a scaffold protein called NF-kB essential modulator
(NEMO). The IKK complex is activated by phosphorylation
of Ser177 and Ser181 and in turn activates IkB [62].
The association of NF-kB with IkB sequesters the
dimeric NF-kB complex in the cytoplasm of the cell.
NF-kB activation requires phosphorylation of the IkBa
molecule on ser32 and ser36 [63]. This dual phosphoryla-
tion causes dissociation from the NF-kB molecule and
targets IkB for ubiquitin conjugation and subsequent pro-
teasomal degradation. The dissociation of IkB from NF-kB
unmasks a nuclear localization signal resulting in the trans-
location of NF-kB to the nucleus. Upon translocation to
the nucleus NF-kB binds to NF-kB binding elements,
where it induces transcription of many genes associated
with inflammation such as TNF-a, IL-1b, iNOS and cyclo-
oxygenase-2 (COX-2) [61].
The 26S proteasome is less active in aged individuals, and
this may impact upon the NF-kB pathway; Huber et al.
([64]) demonstrated in a hepatic ischaemia–reperfusion
model that inactivation of proteosomal activity led to an
increase in tissue damage but a decrease in NF-kB activity
with age due to the prevention of the recruitment of ubiq-
uitinated IkBa to the proteasome, thereby preventing release
from the complex, nuclear localization and transcriptional
activity of NF-kB. Other studies have shown that aged
rodents have increased levels of NF-kB binding to DNA in
both muscle [65] and brain tissue [66] compared to young
animals. Although a number of differences between rodent
and human immunology have been well documented, evi-
dence of human tissue-specific increases in NF-kB binding
have been documented [67], although to date the effect of
age on NF-kB binding in human macrophages has not been
reported.
The inﬂammaging, TLR and infection paradox
The collected evidence for the effect of age on TLR signalling
does not suggest an amplification of response to ligand as a
mechanism for the increased levels of circulating cytokines
with age. Moreover, older adults are more prone to infection
and have impaired immune responses. Together, these data
suggest that an ineffective clearance of infectious agents and
prolonged phagocytic cell activation is the primary driver for
increasing the inflammatory response and may arise from
ineffective signalling from TLRs. Consequently, the released
cytokines and chemokines would serve as signals to further
phagocytic recruitment, and further activation of inflamma-
tory responses while ineffective removal of pathogen sus-
tains the stimulus (Fig. 2). We have proposed recently that
the disturbance to the cellular redox state will impair cell
death pathways and may lead to longer-lived, activated cells
[61].
The inability of older macrophages to mount an effective
innate response to challenge poses a significant health risk,
notably the persistence of infection and chronicity of
inflammation. Restoration of effective bacterial clearance
and the phenotypic switching of macrophages to anti-
inflammatory cells or their apoptosis are likely to be the key
features of an effective strategy to reduce age-associated
inflammatory damage.
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